Leiomyosarcoma: Current Clinical Management and Future Horizons.

导出原文传递

翻译打印收藏纠错

作者： Nicolas,Devaud ^[1] ; Olga,Vornicova ^[2] ; Albiruni R,Abdul Razak ^[2] ; Korosh,Khalili ^[3] ; Elizabeth G,Demicco ^[4] ; Cristina,Mitric ^[5] ; Marcus Q,Bernardini ^[5] ; Rebecca A,Gladdy ^[6]

作者单位： Instituto Oncologico Fundacion Arturo Lopez Perez (FALP), Santiago, Chile. ^[1] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. ^[2] Joint Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada. ^[3] Department of Laboratory Medicine and Pathobiology, Sinai Health System, University of Toronto, Toronto, Ontario, Canada. ^[4] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario, Canada. ^[5] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Division of General Surgery, Sinai Health System, University of Toronto, Toronto, Ontario, Canada. Electronic address: Rebecca.gladdy@sinaihealth.ca. ^[6]

关键词 Leiomyosarcoma Metastasis Retroperitoneum Soft tissue sarcoma Systemic treatment Uterine sarcoma Vascular origin

主题词综合疗法(Combined Modality Therapy);无病生存(Disease-Free Survival);人类(Humans);平滑肌肉瘤(Leiomyosarcoma);肉瘤(Sarcoma);软组织肿瘤(Soft Tissue Neoplasms)

DOI 10.1016/j.soc.2022.03.011

PMID 35715148

发布时间 2022-07-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交